Edward J Sitar's Net Worth
-$132 Thousand
Who is Edward J Sitar?
Edward J Sitar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Timber Pharmaceuticals, Inc., INNOVATE BIOPHARMACEUTICALS, INC., and CANCER GENETICS, INC.
SEC CIK
Edward J Sitar's CIK is 0001603489
Past Insider Trading and Trends
2020 was Edward J Sitar's most active year for acquiring shares with 9 total transactions. Edward J Sitar's most active month to acquire stocks was the month of March. 2016 was Edward J Sitar's most active year for disposing of shares, totalling 1 transactions. Edward J Sitar's most active month to dispose stocks was the month of May. 2021 saw Edward J Sitar paying a total of $75,200.00 for 605,091 shares, this is the most they've acquired in one year. In 2016 Edward J Sitar cashed out on 3,333 shares for a total of $5,192.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Timber Pharmaceuticals, Inc. (TMBR) No price found
InvestorEdward J Sitar owns 11,127 units of Common Stock, par value $0.001 per share. In the year 2020 Edward J Sitar filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +91.84% | 5.33K |
—
|
—
| 11.13K |
Apr 15
| |||
Form 4
| +75.76% | 2.5K |
$1.63 | $4,072.50 | 5.8K |
Dec 15
| |||
Form 4
| +1,000.00% | 150K |
—
|
—
| 165K |
Apr 15
| |||
Form 4
|
∞
| 15K |
$0.46 | $6,900.00 | 15K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001
Chief Financial OfficerEdward J Sitar owns 194,338 units of Common stock which is worth $0.19. In the year 2019 Edward J Sitar filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.36% | 15K |
$1.22 | $18,300.00 | 194.34K |
Sep 14
| |||
Form 4
| +38.66% | 50K |
$1.00 | $50,000.00 | 179.34K |
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +90.76% | 61.54K |
$0.65 | $39,999.70 | 129.34K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
∞
| 67.8K |
—
|
—
| 67.8K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CANCER GENETICS, INC (VYNT) Snapshot price: $0.194
Chief Financial OfficerEdward J Sitar owns 14,167 units of Common Stock, par value $0.0001 per share which is worth $2,748.40. In the year 2014 Edward J Sitar filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.05% | -3.33K |
$1.56 | -$5,192.81 | 14.17K |
Nov 16
| |||
Form 4
| +40.00% | 5K |
—
|
—
| 17.5K |
Nov 12
| |||
Form 4
| +8.70% | 1K |
$6.99 | $6,991.90 | 12.5K |
Mar 16
| |||
Form 4
| +4.55% | 500 |
$6.26 | $3,130.00 | 11.5K |
Dec 11 - Dec 12
| |||
Form 4
| +1,000.00% | 10K |
—
|
—
| 11K |
May 22
| |||
Form 4
|
∞
| 1K |
$10.67 | $10,670.00 | 1K |
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||